- Home
- APLM vs PEV Comparison
APLM vs PEV Comparison
Compare APLM & PEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- PEV
- Stock Information
- Founded
- APLM 2016
- PEV 2002
- Country
- APLM United States
- PEV United States
- Employees
- APLM N/A
- PEV N/A
- Industry
- APLM Blank Checks
- PEV Auto Manufacturing
- Sector
- APLM Finance
- PEV Consumer Discretionary
- Exchange
- APLM Nasdaq
- PEV Nasdaq
- Market Cap
- APLM 15.6M
- PEV 15.8M
- IPO Year
- APLM N/A
- PEV 2022
- Fundamental
- Price
- APLM $0.14
- PEV $0.81
- Analyst Decision
- APLM Strong Buy
- PEV
- Analyst Count
- APLM 2
- PEV 0
- Target Price
- APLM $4.25
- PEV N/A
- AVG Volume (30 Days)
- APLM 876.0K
- PEV 14.8M
- Earning Date
- APLM 08-14-2024
- PEV 11-12-2024
- Dividend Yield
- APLM N/A
- PEV N/A
- EPS Growth
- APLM N/A
- PEV N/A
- EPS
- APLM N/A
- PEV N/A
- Revenue
- APLM $2,101,000.00
- PEV $10,761,000.00
- Revenue This Year
- APLM N/A
- PEV N/A
- Revenue Next Year
- APLM N/A
- PEV N/A
- P/E Ratio
- APLM N/A
- PEV N/A
- Revenue Growth
- APLM 70.54
- PEV 97.81
- 52 Week Low
- APLM $0.11
- PEV $0.32
- 52 Week High
- APLM $2.06
- PEV $1.79
- Technical
- Relative Strength Index (RSI)
- APLM 48.96
- PEV 61.06
- Support Level
- APLM $0.13
- PEV $0.61
- Resistance Level
- APLM $0.17
- PEV $0.94
- Average True Range (ATR)
- APLM 0.01
- PEV 0.15
- MACD
- APLM -0.00
- PEV 0.04
- Stochastic Oscillator
- APLM 34.48
- PEV 44.78
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About PEV Phoenix Motor Inc.
Phoenix Motor Inc is an electrification solutions provider for the commercial vehicle industry as well as other industries. It designs, develops, manufactures, assembles, and integrates electric drive systems and light and medium-duty electric vehicles (EVs) and markets and sells electric vehicle chargers for the commercial and residential markets. The company operates two primary brands, Phoenix Motorcars, which focuses on commercial products including medium-duty electric vehicles, chargers, and electric forklifts, and EdisonFuture which intends to offer light-duty electric vehicles.